PVLA

Palvella Therapeutics, Inc. Common Stock
PVLA

Overview Fund Activity

24 hedge funds and large institutions have $10.1M invested in Palvella Therapeutics, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 3 closing their positions.

Holders
24
Holders Change
+3
Holders Change %
+14.29%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ACM
1
ADAR1 Capital Management
Texas
$2.4M
2
BCM
2
BML Capital Management
Indiana
$699K
3
CM
3
CM Management
Florida
$373K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$533K
5
FLSM
5
Frazier Life Sciences Management
California
$267K

Top Sellers

1
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$49K
2
LCM
2
Lynx1 Capital Management
Puerto Rico
$621K
3
UBS Group
3
UBS Group
Switzerland
$5.77K
4
TRCT
4
Tower Research Capital (TRC)
New York
$0
5
HVIA
5
Hudson Valley Investment Advisors
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
– – -334 Closed
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
– – -4 Closed
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
1
2